Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: A prospective, randomized, multicenter study

International Journal of Cardiovascular Imaging

Volumn 30, Issue 5, 2014, Pages 979-989

  Tejani, Furqan H ^a   Thompson, Randall C ^b   Kristy, Rita ^c   Bukofzer, Stan ^d  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^d NONE

Author keywords

Caffeine; Myocardial perfusion imaging; Pharmacologic stress; Regadenoson

Indexed keywords

CAFFEINE; CREATINE KINASE MB; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PLACEBO; REGADENOSON; TETROFOSMIN; TROPONIN T; ADENOSINE A2 RECEPTOR AGONIST; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOCARDIAL PERFUSION IMAGING; NAUSEA AND VOMITING; PHARMACOLOGIC STRESS TESTING; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; EXERCISE TEST; MIDDLE AGED; SCINTISCANNING; VERY ELDERLY;

ADENOSINE A2 RECEPTOR AGONISTS; ADULT; AGED; AGED, 80 AND OVER; CAFFEINE; CORONARY DISEASE; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PURINES; PYRAZOLES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84905716103     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0419-7     Document Type: Article

References (20)

1. Astellas Pharma US Inc. (2012) Lexiscan® (regadenoson) injection for intravenous administration. Full prescribing information. http://www.astellas. us/docs/lexiscan.pdf. Accessed 19 Aug 2013
2. Al Jaroudi W, Iskandrian AE (2009) Regadenoson: a new myocardial stress agent. J Am Coll Cardiol 54(13):1123-1130. doi:10. 1016/j.jacc.2009.04.089
3. Ananthasubramaniam K, Weiss R, McNutt B, Klauke B, Feaheny K, Bukofzer S (2012) A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. J Nucl Cardiol 19(2):319-329. doi:10.1007/s12350-011-9508-3
4. Prenner BM, Bukofzer S, Behm S, Feaheny K, McNutt BE (2012) A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease. J Nucl Cardiol 19(4):681-692. doi:10.1007/s12350-012-9547-4
5. Daly JW, Hide I, Müller CE, Shamim M (1991) Caffeine analogs: structure-activity relationships at adenosine receptors. Pharmacology 42(6):309-321
6. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83-133 (Pubitemid 29113867)
7. 2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284(3):1066-1073
8. Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao S-S (2009) American Society of Nuclear Cardiology (ASNC) imaging guidelines for nuclear cardiology procedures-stress protocols and tracers. http://www.asnc.org/ imageuploads/ImagingGuidelines StressProtocols021109.pdf. Accessed 15 Aug 2013
9. Gaemperli O, Schepis T, Koepfli P, Siegrist PT, Fleischman S, Nguyen P, Olmsted A, Wang W, Lieu H, Kaufmann PA (2008) Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol 51(3):328-329. doi:10.1016/j. jacc.2007.10.014
10. Tejani FH, Thompson RC, Iskandrian AE, McNutt BE, Franks B (2011) Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study. J Nucl Cardiol 18(1):73-81. doi:10.1007/s12350-010-9311-6
11. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539-542 (Pubitemid 34262671)
12. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14(5):645-658. doi:10.1016/j.nucl card.2007.06.114
13. 2A agonist regadenoson versus adenosine in myocardial perfusion imaging. J Am Coll Cardiol Imaging 1(2):307-316. doi:10.1016/j.jcmg.2008.02.003
14. 2A-adenosine receptor reserve for coronary vasodilation. Circulation 98(7):711-718
15. Zoghbi GJ, Htay T, Aqel R, Blackmon L, Heo J, Iskandrian AE (2006) Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol 47(11):2296-2302. doi:10.1016/j.jacc.2005. 11.088
16. Bangalore S, Parkar S, Messerli FH (2007) "One" cup of coffee and nuclear SPECT to go. J Am Coll Cardiol 49(4):528; author reply 528-529. doi:10.1016/j.jacc.2006.10.044
17. 2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 46(11):2069-2075. doi:10.1016/j.jacc.2005.05.097
18. Shapiro RE (2007) Caffeine and headaches. Neurol Sci 28(Suppl 2):S179-S183. doi:10.1007/s10072-007-0773-5
19. Olesen J (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):S9-S160
20. Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, Berman DS (2013) Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 61(10):1054-1065. doi:10.1016/j.jacc.2012.11.056